AUTOGENOUS ARTERIOVENOUS FISTULA DYSFUNCTION AND ASSOCIATED FACTORS IN PATIENTS WITH END-STAGE KIDNEY DISEASE UNDERGOING MAINTENANCE HEMODIALYSIS
Main Article Content
Abstract
Objective: To determine the prevalence of autogenous arteriovenous fistula dysfunction and to investigate associated factors in patients with end-stage kidney disease undergoing maintenance hemodialysis.
Subject and methods: An analytical cross-sectional study was conducted in 126 patients with end-stage kidney disease receiving maintenance hemodialysis via autogenous arteriovenous fistula at the Nephrology - Hemodialysis Department, Trung Vuong Hospital from June 2025 to April 2026.
Results: The prevalence of autogenous arteriovenous fistula dysfunction was 22.2%. Patients with autogenous arteriovenous fistula dysfunction had longer durations of chronic kidney disease, end-stage kidney disease, and autogenous arteriovenous fistula use compared with those without dysfunction. On Doppler ultrasound, the dysfunction group had a smaller venous diameter at 10 cm from the anastomosis and higher proportions of draining vein wall thickening, anastomotic stenosis, outflow stenosis, and outflow thrombosis. Multivariable analysis identified autogenous arteriovenous fistula duration, venous flow at 10 cm, and draining vein wall thickening as independent associated factors.
Conclusion: Autogenous arteriovenous fistula dysfunction was observed in 22.2% of patients undergoing maintenance hemodialysis. Clinical monitoring combined with Doppler ultrasonography may be useful for early detection of autogenous arteriovenous fistula dysfunction.
Article Details
Keywords
Autogenous arteriovenous fistula (AVF), dysfunction, prevalence, associated factors, end-stage kidney disease.
References
[2] Voorzaat B.M, Janmaat C.J et al. Patency outcomes of arteriovenous fistulas and grafts for hemodialysis access: a trade-off between nonmaturation and long-term complications. Kidney360, 2020, 1 (9): 916-24. doi: 10.34067/kid.0000462020.
[3] Cristino D, Neves J.R et al. Patency and maturation rates after forearm arteriovenous fistulas: systematic review with meta-analysis. Journal of Nephrology, 2025, 38 (8): 2111-2127. doi: 10.1007/s40620-025-02346-x.
[4] KDOQI adequacy guidelines. Clinical practice guidelines for peritoneal adequacy, update 2006. American Journal of Kidney Diseases, 2006, 48: S91-S7. doi: 10.1053/j.ajkd.2006.05.016.
[5] Zhang F, Li J et al. Risk factors for arteriovenous fistula dysfunction in hemodialysis patients: a retrospective study. Scientific Reports, 2023, 13 (1): 21325. doi: 10.1038/s41598-023-48691-4.
[6] Al-Jaishi A.A, Oliver M.J et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis, 2014, 63 (3): 464-78. doi: 10.1053/j.ajkd.2013.08.023.
[7] Ramanan S.V, Prabhu R.A et al. Outcomes and predictors of failure of arteriovenous fistulae for hemodialysis. International Urology and Nephrology, 2022, 54 (1): 185-92. doi: 10.1007/s11255-021-02908-5.
[8] Robbin M.L, Greene T et al. Prediction of arteriovenous fistula clinical maturation from postoperative ultrasound measurements: findings from the hemodialysis fistula maturation study. Journal of the American Society of Nephrology, 2018, 29 (11): 2735-2744. doi: 10.1681/asn.2017111225.
[9] Raksasuk S, Naweera W et al. Comparing non-invasive diagnostic methods for arteriovenous fistula stenosis: a prospective study. Journal of Ultrasound, 2023, 26 (3): 687-693. doi: 10.1007/s40477-022-00731-x.
[10] Granata A, Maccarrone R et al. A novel duplex ultrasound-based classification of outflow stenosis in native arterio-venous fistulas for hemodialysis. BMC Nephrology, 2025, 26 (1): 670. doi: 10.1186/s12882-025-04595-1.